1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: AI-Enabled Digital Pathology Software Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. AI-Enabled Digital Pathology Software Market, by Function
8.1.1 Image Analysis
8.1.1.1. Market Revenue and Forecast
8.1.2. Predictive Analytics
8.1.2.1. Market Revenue and Forecast
8.1.3. Workflow Management
8.1.3.1. Market Revenue and Forecast
9.1. AI-Enabled Digital Pathology Software Market, by Application
9.1.1. Disease Diagnosis
9.1.1.1. Market Revenue and Forecast
9.1.2. Drug Discovery & Development
9.1.2.1. Market Revenue and Forecast
10.1. AI-Enabled Digital Pathology Software Market, by Technology
10.1.1. Deep Learning/CNNs
10.1.1.1. Market Revenue and Forecast
10.1.2. Generative AI (GANs)
10.1.2.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Function
11.1.2. Market Revenue and Forecast, by Application
11.1.3. Market Revenue and Forecast, by Technology
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Function
11.1.4.2. Market Revenue and Forecast, by Application
11.1.4.3. Market Revenue and Forecast, by Technology
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Function
11.1.5.2. Market Revenue and Forecast, by Application
11.1.5.3. Market Revenue and Forecast, by Technology
11.2. Europe
11.2.1. Market Revenue and Forecast, by Function
11.2.2. Market Revenue and Forecast, by Application
11.2.3. Market Revenue and Forecast, by Technology
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Function
11.2.4.2. Market Revenue and Forecast, by Application
11.2.4.3. Market Revenue and Forecast, by Technology
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Function
11.2.5.2. Market Revenue and Forecast, by Application
11.2.5.3. Market Revenue and Forecast, by Technology
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Function
11.2.6.2. Market Revenue and Forecast, by Application
11.2.6.3. Market Revenue and Forecast, by Technology
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Function
11.2.7.2. Market Revenue and Forecast, by Application
11.2.7.3. Market Revenue and Forecast, by Technology
11.3. APAC
11.3.1. Market Revenue and Forecast, by Function
11.3.2. Market Revenue and Forecast, by Application
11.3.3. Market Revenue and Forecast, by Technology
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Function
11.3.4.2. Market Revenue and Forecast, by Application
11.3.4.3. Market Revenue and Forecast, by Technology
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Function
11.3.5.2. Market Revenue and Forecast, by Application
11.3.5.3. Market Revenue and Forecast, by Technology
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Function
11.3.6.2. Market Revenue and Forecast, by Application
11.3.6.3. Market Revenue and Forecast, by Technology
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Function
11.3.7.2. Market Revenue and Forecast, by Application
11.3.7.3. Market Revenue and Forecast, by Technology
11.4. MEA
11.4.1. Market Revenue and Forecast, by Function
11.4.2. Market Revenue and Forecast, by Application
11.4.3. Market Revenue and Forecast, by Technology
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Function
11.4.4.2. Market Revenue and Forecast, by Application
11.4.4.3. Market Revenue and Forecast, by Technology
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Function
11.4.5.2. Market Revenue and Forecast, by Application
11.4.5.3. Market Revenue and Forecast, by Technology
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Function
11.4.6.2. Market Revenue and Forecast, by Application
11.4.6.3. Market Revenue and Forecast, by Technology
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Function
11.4.7.2. Market Revenue and Forecast, by Application
11.4.7.3. Market Revenue and Forecast, by Technology
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Function
11.5.2. Market Revenue and Forecast, by Application
11.5.3. Market Revenue and Forecast, by Technology
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Function
11.5.4.2. Market Revenue and Forecast, by Application
11.5.4.3. Market Revenue and Forecast, by Technology
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Function
11.5.5.2. Market Revenue and Forecast, by Application
11.5.5.3. Market Revenue and Forecast, by Technology
12.1. Roche (F. Hoffmann-La Roche Ltd)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Paige AI
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ibex Medical Analytics
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Philips (Koninklijke Philips N.V
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Indica Labs
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Aiforia Technologies
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Proscia
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Tempus
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Visiopharm A/S
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. PathAI
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
